InSound XT Gets FDA Nod To Become First Extended-Wear Hearing Aid
This article was originally published in The Gray Sheet
Executive SummaryInSound Medical intends to create an installment payment plan for its InSound XT Series extended-wear disposable hearing aid, to be priced competitively with high-end digital aids in the $3,000 range
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.